Scott Michael Palmer, MD

Professor of Medicine
Member in the Duke Clinical Research Institute
Vice-Chair for Research in the Department of Medicine
Professor in Immunology
Professor in Population Health Sciences
Core Faculty in Innovation & Entrepreneurship
Campus mail 2085 Msrb2 2 Genome Ct, Durham, NC 27710
Phone (919) 684-0245
Email address scott.palmer@duke.edu

Dr. Palmer leads a successful program of clinical, basic and translational research in transplantation and advanced lung diseases. He currently directs the pulmonary research program at the Duke Clinical Research Institute (DCRI) and serves as Vice Chair for Research in the Department of Medicine.

Dr. Palmer has over 150 peer reviewed publications, received numerous awards, including election into the American Society for Clinical Investigation (ASCI) in 2012, chaired many sessions at national and international meetings, serves regularly on NIH study sections, and is on the editorial board of many prominent journals. He is also Associate Director of the Clinical Research Training Program at Duke and has personally mentored over 40 pre-and post-doctoral trainees, many of whom are now engaged in their own successful research careers.

His scientific accomplishments include the first human studies to demonstrate the importance of innate immunity in transplant rejection and completion of a prospective multicenter study that improved CMV prevention after lung transplantation.

Current basic projects in the lab are studying the role of the matrix in the activation of innate immunity in pulmonary transplant rejection, and epithelial injury and repair in the development of toxin induced bronchiolitis obliterans. Translational and human projects are studying predictors of lung transplant survival in the UNOS database, immune monitoring to predict CMV infection and acute rejection after lung transplantation, and the use of novel inhaled antibiotics in lung transplantation. The lab is also using cutting edge whole exome genetic sequencing to identify genetic predictors of transplant rejection.

Dr. Palmer also leads trials coordinated through the DCRI that study the natural history and investigate new treatments for idiopathic pulmonary fibrosis (IPF), chronic lung transplant rejection, and posttransplant cytomegalovirus infection.

Education and Training

  • Fellow, Pulmonary Medicine, Medicine, Duke University, 1996 - 1999
  • Medical Resident, Medicine, Duke University, 1993 - 1996
  • M.H.S., Duke University, 2000
  • M.D., Duke University, 1993

Publications

Chery, G. S., S. M. Palmer, L. D. Snyder, A. L. Gray, J. L. Todd, G. Harrison, and E. N. Pavlisko. “Post-Transplant Lymphoproliferative Disorder Erosion Into A Large Pulmonary Artery With Death Secondary To Hemorrhagic Shock.” In American Journal of Respiratory and Critical Care Medicine, Vol. 191. AMER THORACIC SOC, 2015.

Scholars@Duke

Chery, G. S., S. M. Palmer, L. D. Snyder, J. L. Todd, and C. Wolfe. “Brincidofovir In Progressive Multifocal Leukoencephalopathy After Lung Transplant.” In American Journal of Respiratory and Critical Care Medicine, Vol. 191. AMER THORACIC SOC, 2015.

Scholars@Duke

Copeland, CA Finlen, J. A. Martissa, C. W. Frankel, E. C. Benedetti, E. Callahan, D. Ross, S. M. Palmer, et al. “A Prospective Multicenter Assessment Of Aztreonam Lysine For Inhalation In The Treatment Of Lung Transplant Recipients With Chronic Lung Allograft Dysfunction.” In American Journal of Respiratory and Critical Care Medicine, Vol. 191. AMER THORACIC SOC, 2015.

Scholars@Duke

Snyder, L. D., C. Chan, D. Kwon, J. Yi, J. A. Martissa, CA Finlen Copeland, R. Osborne, S. D. Sparks, S. M. Palmer, and K. J. Weinhold. “Polyfunctional T Cell Immunity Predicts Cytomegalovirus Infection After Lung Transplant.” In American Journal of Respiratory and Critical Care Medicine, Vol. 191. AMER THORACIC SOC, 2015.

Scholars@Duke

Porteous, M., D. J. Lederer, S. M. Palmer, E. Cantu, R. J. Shah, S. L. Bellamy, V. N. Lama, et al. “Explanatory Model For Primary Graft Dysfunction Among Patients With Pulmonary Hypertension.” In American Journal of Respiratory and Critical Care Medicine, Vol. 191. AMER THORACIC SOC, 2015.

Scholars@Duke

Frankel, C. W., L. D. Snyder, C Finlen Copeland, E. Benedetti, E. Serrano, J. A. Martissa, and S. M. Palmer. “Inhaled Aztreonam In Lung Transplant Recipients: A Single Center Retrospective Cohort Study.” In American Journal of Respiratory and Critical Care Medicine, Vol. 191. AMER THORACIC SOC, 2015.

Scholars@Duke

Speicher, Paul J., Asvin M. Ganapathi, Brian R. Englum, Brian C. Gulack, Asishana A. Osho, Sameer A. Hirji, Anthony W. Castleberry, Laurie D. Snyder, R. Duane Davis, and Matthew G. Hartwig. “Single-lung transplantation in the United States: what happens to the other lung?.” In J Heart Lung Transplant, 34:36–42, 2015. https://doi.org/10.1016/j.healun.2014.08.018.

PMID
25305097
Full Text

Gowdy, Kymberly M., Tereza Martinu, Julia L. Nugent, Nicholas D. Manzo, Helen L. Zhang, Francine L. Kelly, Michael J. Holtzman, and Scott M. Palmer. “Impaired CD8(+) T cell immunity after allogeneic bone marrow transplantation leads to persistent and severe respiratory viral infection..” Transpl Immunol 32, no. 1 (January 2015): 51–60. https://doi.org/10.1016/j.trim.2014.10.005.

PMID
25446809
Full Text

Morgan, Daniel L., B Alex Merrick, Kevin E. Gerrish, Patricia S. Stockton, Yu Wang, Julie F. Foley, William M. Gwinn, et al. “Gene expression in obliterative bronchiolitis-like lesions in 2,3-pentanedione-exposed rats..” Plos One 10, no. 2 (2015). https://doi.org/10.1371/journal.pone.0118459.

PMID
25710175
Full Text

Osho, Asishana A., Anthony W. Castleberry, Laurie D. Snyder, Scott M. Palmer, Mark Stafford-Smith, Shu S. Lin, R. Duane Davis, and Matthew G. Hartwig. “The Chronic Kidney Disease Epidemiology Collaboration (CKDEPI) equation best characterizes kidney function in patients being considered for lung transplantation..” J Heart Lung Transplant 33, no. 12 (December 2014): 1248–54. https://doi.org/10.1016/j.healun.2014.06.011.

PMID
25107351
Full Text

Pages